: Treatment of heartburn and acid reflux.
: As a delayed-release capsule, it is acid-labile and must be protected from gastric juice; it is usually absorbed in the small intestine. Peak plasma concentrations occur 1–3 hours after oral dosing.
: Increased risk of Clostridioides difficile infection and community-acquired pneumonia.
: Including short-term treatment of active duodenal ulcers.
: Treatment of heartburn and acid reflux.
: As a delayed-release capsule, it is acid-labile and must be protected from gastric juice; it is usually absorbed in the small intestine. Peak plasma concentrations occur 1–3 hours after oral dosing. prilosec
: Increased risk of Clostridioides difficile infection and community-acquired pneumonia. : Treatment of heartburn and acid reflux
: Including short-term treatment of active duodenal ulcers. prilosec